Akebia Therapeutics Aktie

Kaufen
Verkaufen
0,98 EUR -0,03 EUR -3,41 %
1,14 USD -0,01 USD -0,87 %
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln! Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO! Bei einem anderen Broker handeln
Marktkap. 221,95 Mio. EUR KGV -4,43

WKN A1XF0S

ISIN US00972D1054

Symbol AKBA


Akebia Therapeutics Aktie Analyse

06.08.19 Akebia Therapeutics Buy H.C. Wainwright & Co.
11.07.19 Akebia Therapeutics Buy H.C. Wainwright & Co.
10.08.18 Akebia Therapeutics Buy Needham & Company, LLC
06.06.18 Akebia Therapeutics Buy H.C. Wainwright & Co.
07.12.17 Akebia Therapeutics Buy BTIG Research
15.09.17 Akebia Therapeutics Sector Perform RBC Capital Markets
10.07.17 Akebia Therapeutics Buy H.C. Wainwright & Co.
27.04.17 Akebia Therapeutics Buy Needham & Company, LLC
27.04.17 Akebia Therapeutics Buy H.C. Wainwright & Co.
27.12.16 Akebia Therapeutics Buy H.C. Wainwright & Co.
16.03.16 Akebia Therapeutics Buy Needham & Company, LLC
15.12.15 Akebia Therapeutics Buy Needham & Company, LLC
15.12.15 Akebia Therapeutics Buy H.C. Wainwright & Co.
07.12.15 Akebia Therapeutics Buy H.C. Wainwright & Co.
14.05.15 Akebia Therapeutics Buy Brean Capital
11.05.15 Akebia Therapeutics Buy Needham & Company, LLC